Published in Mol Endocrinol on June 01, 1994
Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res (2001) 4.23
Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev (2004) 2.35
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol (2008) 1.89
BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol (2000) 1.80
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res (2006) 1.58
Differential gene regulation by the SRC family of coactivators. Genes Dev (2004) 1.41
The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Mol Cell Biol (2007) 1.34
Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol Cell Biol (1995) 1.17
Med1 plays a critical role in the development of tamoxifen resistance. Carcinogenesis (2012) 1.13
Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell (2002) 1.05
LKB1 catalytic activity contributes to estrogen receptor alpha signaling. Mol Biol Cell (2009) 1.00
Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. Nucleic Acids Res (1998) 0.99
Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha. Proc Natl Acad Sci U S A (1999) 0.97
Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha. Mol Biol Cell (2010) 0.95
HMGN1 modulates estrogen-mediated transcriptional activation through interactions with specific DNA-binding transcription factors. Mol Cell Biol (2007) 0.93
HRTBLDb: an informative data resource for hormone receptors target binding loci. Nucleic Acids Res (2009) 0.85
Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids (2012) 0.84
Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations. J Biol Chem (2009) 0.84
Analysis of gene expression profiles in largemouth bass exposed to 17-beta-estradiol and to anthropogenic contaminants that behave as estrogens. Ecotoxicology (2003) 0.83
Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology. Acta Pharmacol Sin (2014) 0.82
Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Int J Cancer (2010) 0.81
Modulation of Estrogen Response Element-Driven Gene Expressions and Cellular Proliferation with Polar Directions by Designer Transcription Regulators. PLoS One (2015) 0.77
Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice. Mol Cancer (2012) 0.77
Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells. Oncotarget (2016) 0.75
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia (2012) 7.11
Cost analysis of early discharge after hip fracture. BMJ (1993) 6.64
The euthanasia controversy. Decision-making in extreme cases. Med J Aust (1995) 5.96
The role of the church in developing the law. J Med Ethics (2002) 5.39
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62
Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation (2001) 2.73
Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol (1987) 2.54
Analysis of urea distribution volume in hemodialysis. Nephron (1994) 2.48
Revealing false paternity: some ethical considerations. Lancet (2001) 2.48
Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res (1988) 2.28
A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell (1980) 2.28
Redesign of PCR primers for mitochondrial cytochrome c oxidase subunit I for marine invertebrates and application in all-taxa biotic surveys. Mol Ecol Resour (2013) 2.27
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res (2001) 2.21
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res (1982) 2.15
Inhibition of breast cancer growth by suramin. J Natl Cancer Inst (1992) 2.10
Do case studies mislead about the nature of reality? J Med Ethics (1999) 1.99
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine (2000) 1.95
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med (1989) 1.88
Quality improvement for patients with hip fracture: experience from a multi-site audit. Qual Saf Health Care (2002) 1.83
Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis (2003) 1.81
The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med (2000) 1.79
Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet (1989) 1.77
Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun (1979) 1.76
Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell (1999) 1.73
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol (2001) 1.66
Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci U S A (1987) 1.64
Circadian variation in human ventricular refractoriness. Circulation (1995) 1.61
Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol (1994) 1.52
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology (1986) 1.50
An investigation of patients' motivations for their participation in genetics-related research. J Med Ethics (2010) 1.48
Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci U S A (1992) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene (1990) 1.47
Isolation of Pseudomonas pseudomallei from clay layers at defined depths. Am J Epidemiol (1979) 1.47
Silent thyrotoxic thyroiditis in association with chronic adrenocortical insufficiency. Arch Intern Med (1980) 1.45
The impact of fluoride application training: survey of trained dental nurses from King's College Hospital NHS Trust. Br Dent J (2012) 1.43
Prevention of oral bacterial flora transmission by using mouth-to-mask ventilation during CPR. J Emerg Med (1991) 1.43
Informed decision making for cancer screening--not all of the ethical issues have been considered. Cytopathology (2003) 1.40
RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol (1996) 1.39
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res (1998) 1.37
Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem (1987) 1.36
Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene (1995) 1.35
Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res (1989) 1.34
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res (1987) 1.33
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis (1997) 1.32
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem (1984) 1.31
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res (1988) 1.30
Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun (1987) 1.29
Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). Mol Endocrinol (1999) 1.28
Antimicrobial activity of cinnamon and clove oils under modified atmosphere conditions. Int J Food Microbiol (2005) 1.28
Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl (2001) 1.24
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab (1982) 1.20
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J Biol Chem (1981) 1.20
Pneumocystis carinii identified by gram stain of lung imprints. Ann Intern Med (1983) 1.20
Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology (1980) 1.20
Deciding for imperilled newborns: medical authority or parental autonomy? J Med Ethics (2001) 1.20
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene (2001) 1.19
Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer (1998) 1.18
Nottingham Hip Fracture Score: longitudinal and multi-assessment. Br J Anaesth (2012) 1.18
Exercise training soon after myocardial infarction. Am J Cardiol (1979) 1.17
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol (1998) 1.17
Identifying a standard set of outcome parameters for the evaluation of orthogeriatric co-management for hip fractures. Injury (2013) 1.17
Expression of human sequences related to those of mouse mammary tumor virus. J Virol (1988) 1.16
Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol (1988) 1.15
Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res (1988) 1.15
Refractive errors in young children with Down syndrome. Optom Vis Sci (1997) 1.14
Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol (1987) 1.13
The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun (1986) 1.12
Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med (1981) 1.12
Intracapsular hip fracture and the region-specific loss of cortical bone: analysis by peripheral quantitative computed tomography. J Bone Miner Res (2001) 1.12
Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J Biol Chem (1997) 1.11
Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res (1990) 1.10
Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem (1993) 1.10
Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis. Arch Dis Child (1999) 1.10
Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc Natl Acad Sci U S A (1996) 1.10
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10
Identification of glycinexylidide in patients treated with intravenous lidocaine. Clin Pharmacol Ther (1973) 1.09
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol (1995) 1.09
T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol (1994) 1.08
Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. Cancer Res (1982) 1.08
Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis (1995) 1.08
Permissive and instructive induction of adult rodent prostatic epithelium by heterotypic urogenital sinus mesenchyme. Epithelial Cell Biol (1993) 1.07
Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci (1994) 1.07
Dysphagia as the sole manifestation of myasthenia gravis. J Neurol Neurosurg Psychiatry (2005) 1.06
Gallstone perforation of the ileum without obstruction. Postgrad Med J (1984) 1.06
Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer (1998) 1.06
Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol (1989) 1.05
Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol (2000) 1.05
Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. J Endocrinol (2003) 1.05
Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Res (1983) 1.04
Moral intuition, good deaths and ordinary medical practitioners. J Med Ethics (1990) 1.03
Hip fractures in Finland and Great Britain--a comparison of patient characteristics and outcomes. Int Orthop (2001) 1.03
Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells (1996) 1.02
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol (1980) 1.02
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer (1993) 1.02
Pea legumin overexpressed in wheat endosperm assembles into an ordered paracrystalline matrix. Plant Physiol (2001) 1.01
Pediatric cardiopulmonary resuscitation. A review of 130 cases. Clin Pediatr (Phila) (1984) 1.01